Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • john_nl
    Member
    • Feb 2012
    • 13

    Analyzing expression time course with DESeq

    Hello,

    I have 11 samples covering 10 time points. Time point 1 has a control sample and a treated sample. The following 9 time points are all treated samples.

    I wish to be able to compute the ratios between the control sample and the treatment samples at each time point and then plot these ratios in order to observe the general expression trends over time for each gene. Ultimately I want to cluster these profiles in order to identify genes that roughly behave in a similar manner over time.

    DESeq can compute fold changes between two samples and it has the getVarianceStablizedData() function to normalise the data such that it has similar variance (for clustering). In the vignette, the example is with two samples- is it OK to perform the getVarianceStablizedData on the entire set of samples and then compute moderated log fold changes (as in the vignette) at each timepoint (treatedTimepoint_x - control)? For each gene I can then generate a series of moderated fold changes- is it then appropriate to cluster genes based on these profiles?
  • Simon Anders
    Senior Member
    • Feb 2010
    • 995

    #2
    Hi John

    Yes, your analysis problem is precisely the kind of tasks which we had in mind as potential applications for the variance stabilizing transformation. So, go ahead and give it a try.

    Of course, this is not a perfect solution. The VST makes the data only _approximately_ homoskedastic, and it depends on circumstances whether this is good enough. So, inspect your results carefully and think about some sanity checks. The VST works worse, by the way, if your size factors are rather different; I'm still thinking about how to straighten this out.

    Finally, it will make a difference whether you call 'estimateDispersions' with method 'blind' or 'pooled'. I would, in general, recommend the former if you want to cluster samples (because then you want to be unbiased about the samples' relations) and the latter if you cluster by genes (because then it is appropriate to use sample information). However, you cannot use "pooled" because you don't have real replicates, and "blind" will overestimate variance and so might skew the VST in some direction. In principle, a clustering analysis is proper (though not ideal) without replicates, but the VST will have issues handling it well. Hence, again, your mileage will vary.

    In general, analysing RNA-Seq time courses seems to be an open question to me. I have not seen any papers yet suggesting good analysis methods, and there clearly is still work to do for us biostatisticians before we can recommend some standard analysis method.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...